We would also note the markets appear to be well undervalued via the 'rule of 20' theory.
Shares of the related companies are struggling, which can be the norm for investments in out-of-favor businesses.
Ulta shares are getting hit after the beauty store chain issued a weak outlook for its fourth quarter.
Let's check out the charts and indicators.
It can be disturbing to see various names lose value quickly on no news, but here is a method to take advantage of such moves.
The stench wafting off of the heap of bad news and the myriad of issues confronting FB has driven many former friends, including major investors, away.
CRISPR is a gene-editing technique that uses molecular scissors to precisely snip genetic code. With it, researchers have modified genes to help blind people see, cure sickle cell disease in some patients and speed up the development of numerous new drug treatments.
These three companies have something in common, which a disciplined investor should consider going into 2019.
Small improvements are poking through in the social media giant's charts.